Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages

European Respiratory Journal

Volumn 11, Issue 4, 1998, Pages 809-815

  Wang, C H ^a   Liu, C Y ^a   Lin, H C ^a   Yu, C T ^a   Chung, K F ^b   Kuo, H P ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Alveolar macrophages; Nitric oxide; Nitric oxide synthase; Tuberculosis

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; MALE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

CELLS, CULTURED; FEMALE; HUMANS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RESPIRATION; TUBERCULOSIS, PULMONARY; UP-REGULATION;

EID: 0031745963     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11040809     Document Type: Article

References (32)

1. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
2. Sherman MP, Ganz T. Host defense in pulmonary alveoli. Annu Rev Physiol 1992; 54: 331-350.
3. Liew FY, Cox FG. Nonspecific defense mechanism: the role of nitric oxide, Immunol Today 1991; 12: A17-A24.
4. Nathan C. Nitric oxide as a secretary product of mammalian cells. FASEB J 1992; 6: 3051-3064.
5. Nathan CF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-75.
6. Greenberg SS, Xie J, Kolls J, Mason C, Didier P. Rapid induction of mRNA for nitric oxide synthase II in rat alveolar macrophages by intratracheal administration of Mycobacterium tuberculosis and Mycobacterium avium. Proc Soc Exp Biol Med 1995; 209: 46-53.
7. Bermudez LE. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogens by activated human and murine macrophages. The role of nitric oxide. Clin Exp Immunol 1993; 91: 277-281.
8. Doi T, Ando M, Akaike T, Suga M, Sato K, Maeda H. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis. Infect Immun 1993; 61: 1980-1989.
9. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992; 175: 1111-1122.
10. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995; 63: 736-740.
11. Nicholson S, Bonecini-Almeida M da G, Lapa e Sliva JR, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996; 183: 2293-2302.
12. Gustafsson LE, Leon AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and human. Biochem Biophys Res Commun 1991; 181: 852-857.
13. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shebourne E, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 143: 146-147.
14. Kharitonov SA, Wells AU, O'Connor BJ, Hansell D, Cole PJ, Barnes PJ. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 1995; 151: 1889-1893.
15. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993; 48: 1034-1043.
16. Kuo HP, Yu CT. Alveolar macrophage subpopulations in patients with active pulmonary tuberculosis. Chest 1993; 104: 1773-1778.
17. Simon G. Radiography in epidemiological studies and some therapeutic trials. BMJ 1966; 2: 491-494.
18. Godard P, Chaintreuil J, Damon M, el al. Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects. J Allergy Clin Immunol 1982; 70: 88-93.
19. Springall DR, Riveros-Moreno V, Buttery L, et al. Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms. Histochemistry 1992; 98: 259-266.
20. Terenghi G, Riveros-Moreno V, Hudson LD, Ibrahim NB, Polak JM. Immunohistochemistry of nitric oxide synthase demonstrates immunoreactive neuron in spinal cord and dorsal root ganglia of man and rat. J Neurol Sci 1993; 118:34-37.
21. Most J, Neumayer H, Dierich MP. Cytokine-induced generation of multinucleated giant cells in vitro requires interferon-gamma and expression of LFA-1. Eur J Immunol 1990; 20: 1661-1667.
22. Zhang Y, Doerfler M, Lee TC, Guillemin B, Rom WN. Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components. J Clin Invest 1993; 91: 2076-2083.
23. Kamijo R, Harada H, Matsuyama T, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994; 263: 1612-1615.
24. Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 1993; 167: 1358-1363.
25. Padgett EL, Pruett SB. Evaluation of nitrite production by human monocyte-derived macrophages. Biochem Biophys Res Commun 1992; 186: 775-781.
26. Murray HW, Teitelbaum RF. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect Dis 1992; 165: 513-517.
27. Kolb JP, Paul-Eugene N, Damais C, Yamaoka K, Drapier JC, Dugas B. Interleukin-4 stimulate cGMP production by IF N-gamma-activated human monocytes. J Biol Chem 1994; 269: 9811-9816.
28. Dugas B, Mossalayi MD, Damais C, Kolb JP. Nitric oxide production by human monocytes: evidence for a role of CD 23. Immunol Today 1995; 16: 574-580.
29. Dumarey CH, Labrousse V, Rastogi N, Vargaftig BB, Bachelet M. Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J Leukoc Biol 1994; 56: 36-40.
30. Martin JH, Edwards SW. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunol 1993; 150: 3478-3486.
31. Schuller-Levis GB, Levis WR, Ammazzalorso M, Nosrati A, Park E. Mycobacterial lipoarabinomannan induces nitric oxide and tumor necrotic factor alpha production in a macrophage cell line: down regulation by taurine chloramine. Infect Immun 1994; 62: 4671-4674.
32. Adams LB, Fukutomi Y, Krahenbuhl JL. Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Infect Immun 1993; 61: 4173-4181.